The store will not work correctly when cookies are disabled.
NA
ID: ALA4537358
PubChem CID: 155548410
Max Phase: Preclinical
Molecular Formula: C19H14FN5O2
Molecular Weight: 363.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1cn(-c2ccc(F)cc2)nn1)C(=O)c1c[nH]c2ccccc12
Standard InChI: InChI=1S/C19H14FN5O2/c20-12-5-7-14(8-6-12)25-11-13(23-24-25)9-22-19(27)18(26)16-10-21-17-4-2-1-3-15(16)17/h1-8,10-11,21H,9H2,(H,22,27)
Standard InChI Key: HZYBDYIAQDEGHU-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
16.8595 -4.6865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5675 -4.2793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2758 -4.6860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2758 -5.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5700 -5.9119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8595 -5.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0543 -5.7597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5358 -5.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0544 -4.4317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2623 -6.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0543 -6.7597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6341 -6.1798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4261 -6.3960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0060 -5.8161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8766 -5.0076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6052 -4.6333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1847 -5.2128 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8145 -5.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9766 -5.0007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1891 -4.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9779 -4.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5539 -4.5787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3455 -5.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5559 -5.5841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3459 -4.3666 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.2663 -7.5516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6866 -7.1274 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
8 7 2 0
9 8 1 0
3 9 1 0
7 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
15 14 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 14 2 0
19 17 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
22 25 1 0
11 26 2 0
10 27 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.35 | Molecular Weight (Monoisotopic): 363.1132 | AlogP: 2.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 92.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.55 | CX Basic pKa: ┄ | CX LogP: 2.66 | CX LogD: 2.66 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.42 | Np Likeness Score: -1.81 |
References
1. Xu Z, Zhao SJ, Liu Y.. (2019) 1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships., 183 [PMID:31546197] [10.1016/j.ejmech.2019.111700] |